Hepatic Toxicity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-26
Clinical Trial Update: Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients [Phase 2, Phase 3]
A combined Phase 2/Phase 3 trial investigating silymarin to mitigate chemotherapy toxicity and improve cognition in breast cancer patients.